By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Aerie Pharmaceuticals, Inc. 

1140 Route 22 East
Suite 303
Bridgewater  New Jersey  08807  U.S.A.
Phone: 908-685-0069 Fax: 908-685-0087


SEARCH JOBS


Industry
Pharmaceutical






Company News
Aerie (AERI) To Present At Cantor Fitzgerald's 2nd Annual Healthcare Conference 7/6/2016 10:05:23 AM
Aerie (AERI) Completes Enrollment Of Rocket 4 Phase III Clinical Trial Of Rhopressatm (Netarsudil Ophthalmic Solution) 0.02% 6/16/2016 11:06:45 AM
Aerie (AERI) To Participate In Two Investor Conferences In June 6/2/2016 10:50:07 AM
Aerie (AERI) Completes Enrollment Of Mercury 1 Phase 3 Registration Trial Of Roclatantm (Netarsudil/Latanoprost Ophthalmic Solution) 0.02%/0.005% 5/5/2016 10:27:37 AM
Aerie (AERI) To Present At The Bank of America (BAC) Merrill Lynch 2016 Health Care Conference 5/4/2016 10:50:59 AM
Aerie (AERI) Reports First Quarter 2016 Financial Results And Provides Business Update 5/3/2016 12:14:07 PM
Aerie (AERI) To Announce First Quarter 2016 Financial Results And Host Conference Call On Monday, May 2, 2016 4/25/2016 10:56:48 AM
Aerie (AERI) To Present At The 15th Annual Needham Healthcare Conference 4/5/2016 9:08:49 AM
Aerie (AERI) Initiates Second Phase 3 Registration Trial Of Roclatan (Netarsudil/Latanoprost Ophthalmic Solution) 0.02%/0.005% 3/28/2016 9:19:16 AM
SoCal's Aerie (AERI) Reports Positive Safety Data for Rhopressa 3/18/2016 6:36:24 AM
12345678910
//-->